Boehringer Ingelheim Animal Health: Business Overview, Financials & Competitive Analysis
Boehringer Ingelheim Animal Health scores 7/10 on the AskCyborg Cyborg Score (Solid). Established market leader with diversified animal health portfolio positioned to benefit from pet industry growth and livestock disease prevention trends. Strong market position as second-largest U.S. animal health player with established vaccine and therapeutic portfolios. Backed by a family-owned multinational with global resources. Limited visibility on recent financial.
What is Boehringer Ingelheim Animal Health's industry? Boehringer Ingelheim Animal Health (boehringer-ingelheim.com) operates in Pharmaceuticals. AskCyborg classifies Boehringer Ingelheim Animal Health under Pharmaceuticals in its company registry.
Boehringer Ingelheim Animal Health operates as the second-largest animal health company in the U.S., powered by over 3,000 individuals across key locations including Georgia, Missouri, Iowa, Minnesota, New Jersey, and...
Cyborg Score thesis
Established market leader with diversified animal health portfolio positioned to benefit from pet industry growth and livestock...
Read the full analyst-debate transcript →Get the Latest Boehringer Ingelheim Animal Health Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeBoehringer Ingelheim Animal Health Overview
Pro stress-test →Boehringer Ingelheim Animal Health operates as the second-largest animal health company in the U.S., powered by over 3,000 individuals across key locations including Georgia, Missouri, Iowa, Minnesota, New Jersey, and Puerto Rico. Its extensive animal-health portfolio features highly regarded vaccines, parasite-control products, and pharmaceuticals designed to protect both pets and livestock from disease.
Strategic Profile
Pro stress-test →The company is an integral part of a larger, family-owned global group founded in 1885 in Germany, also specializing in human pharmaceuticals and biopharmaceutical contract manufacturing. Boehringer Ingelheim acquired Merial, uniting the legacies, deep expertise, and broad product portfolios of the two into one of the world's leading animal health companies.
Competitive Landscape
Pro stress-test →Competitors of Boehringer Ingelheim Animal Health include Alltech, Ceva, Advanced Animal Diagnostics, Dechra, Heska and others. The company competes in vaccine development, parasite control, and therapeutic solutions across companion animal and livestock segments with established product brands like NexGard and Ivomec.
Industry Context
Boehringer Ingelheim Animal Health operates in Pharmaceuticals.
Key facts
Founded: 1885 · Headquarters: Ingelheim am Rhein, Germany · Employees: 3,000+ · Revenue: $440.4M (U.S. business)